Exascale Labs Holdings Inc. (XLAB)

NASDAQ: XLAB · Real-Time Price · USD

1.980

-0.290 (-12.78%)

Nov 13, 2026, 3:15 PM EST - Market open

Exascale Labs Holdings Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Revenue	14.82	7.02	1.32
Revenue Growth	111.29%	431.83%	-
Cost of Revenue	12.4	5.91	1.26
Gross Profit	2.42	1.11	0.06
Selling, General & Admin	1.73	1.35	0.54
Research & Development	5.49	2.8	1.37
Operating Expenses	7.22	4.15	1.9
Operating Income	-4.8	-3.04	-1.85
Other Non Operating Income (Expenses)	-7.36	-4.61	-3.11
Pretax Income	-12.16	-7.66	-4.96
Net Income	-12.16	-7.66	-4.96
Net Income to Common	-12.16	-7.66	-4.96
Net Income Growth	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024
Free Cash Flow	-	-1.01	-0.59
Gross Margin	16.31%	15.75%	4.21%
Operating Margin	-32.39%	-43.40%	-139.93%
Profit Margin	-82.05%	-109.18%	-375.73%
Free Cash Flow Margin	-	-14.44%	-44.63%
EBITDA	-4.79	-3.04	-1.84
EBITDA Margin	-32.34%	-43.31%	-139.62%
D&A For EBITDA	0.01	0.01	0
EBIT	-4.8	-3.04	-1.85
EBIT Margin	-32.39%	-43.40%	-139.93%
Advertising Expenses	-	0.16	0.03

SEC Filings: 10-K · 10-Q